Novo Nordisk

Novo Nordisk Takes Prothena’s ATTR Amyloidosis Program

Danish drugmaker Novo Nordisk has acquired Prothena’s clinical-stage stage antibody PRX004 and broader ATTR amyloidosis program, gaining full global rights to the intellectual property and related rights of the ATTR amyloidosis business and pipeline.

Novo Nordisk to Buy Emisphere Technologies

Danish drugmaker Novo Nordisk has agreed to buy US drug delivery company Emisphere Technologies for $1.8 billion.

Evotec Enters Multiple Drug Discovery Pacts

German drug discovery and development company Evotec has struck four separate partnership agreements during August.

Novo Nordisk Buys Cardio-renal Group Corvidia

Novo Nordisk to Upgrade Danish Insulin Plant

AstraZeneca Aims to be Carbon Neutral by 2025

Novo Nordisk Upgrades Danish Plant

Novo Nordisk Launches innovation Platform in China

Novo Nordisk Pharmatech and DKSH in Distribution Pact

Topics • Strategy

Opportunities for Western CDMOs in China

Ossianix and Novo Nordisk link on BBB Research

Novo Nordisk Buys Ziylo Spin-out

Novo Nordisk and Kallyope in Gut-Brain Pact

Novo Nordisk said to plan Major Layoffs

Novo Nordisk Gets EU Nod for Diabetes Drug

Kare Schultz Named CEO of Teva

Novo Nordisk Settles $58.7 Million in US Fines

Sanofi Sues US Merck over Insulin Drug

Azelis Supplies Novo Nordisk Quats

FDA Drug Approvals up Sharply in Q1

Novo Nordisk Invests in UK Research Center

Pharma Shares Rise on Trump Victory

Novo Nordisk Axes Jobs to Cut Costs

Topics • Strategy

Best Pharma Brands

Topics • Strategy

Never Compromise

Novo Nordisk to Make Insulin Pens in Iran

Eli Lilly Copy of $8 Billion Sanofi Insulin Wins EU Approval

Novo Nordisk Launches Diabetes Drug in Germany After Rethink

Novo Nordisk Sees Chance of U.S. Tresiba Launch Before Rivals

China to Launch Fresh Pharmaceutical Bribery Probe

China Investigates France's Sanofi for Alleged Bribery

Top Insulin Maker Novo Caught Up In China's Widening Drug Probes

China Blocks GSK Finance Head From Leaving Country

Sanofi Steps up Diabetes Drive as Rivals Raise the Stakes

Eli Lilly Broadens Diabetes Offer

26 more articles

Top-Feature

When Every Temperature Change Determines the Process

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Predictive Simulation in Pharma Production

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Article

The State of the US Specialty Chemicals Industry

Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Thomson Reuters

Catalent Inc.

Novo Nordisk Pharmatech A/S

Novo Nordisk A/S

Sanofi S.A.

IDA Ireland

CHEManager International c/o Wiley-VCH GmbH

SchüllerConsulting

AstraZeneca